Results 21 to 30 of about 1,261,391 (386)

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

Nature Communications, 2021
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are not currently recommended for pandemic influenza control. New Zealand used these NPIs to eliminate coronavirus disease 2019 during its first wave.
Q. S. Huang, T. Wood, L. Jelley, Tineke Jennings, S. Jefferies, Karen Daniells, A. Nesdale, T. Dowell, N. Turner, P. Campbell-Stokes, M. Balm, H. Dobinson, C. Grant, Shelley James, N. Aminisani, J. Ralston, W. Gunn, J. Bocacao, Jessica Danielewicz, T. Moncrieff, A. McNeill, L. Lopez, Ben Waite, T. Kiedrzynski, H. Schrader, R. Gray, K. Cook, D. Currin, Chaune Engelbrecht, Whitney Tapurau, L. Emmerton, Maxine Martin, M. Baker, Susan L. Taylor, A. Trenholme, Conroy A Wong, S. Lawrence, C. McArthur, A. Stanley, S. Roberts, F. Rahnama, J. Bennett, C. Mansell, M. Dilcher, A. Werno, J. Grant, A. Linden, Ben Youngblood, P. Thomas, NPIsImpactOnFlu Consortium, R. Webby   +50 more
semanticscholar   +1 more source

Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg

Эпидемиология и вакцинопрофилактика, 2020
Background. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health.
M. K. Erofeeva, M. A. Stukova, E. V. Shakhlanskaya, Zh. V. Buzitskaya, V. L. Maksakova, T. I. Krainova, T. M. Chirkina, M. M. Pisareva, D. A. Lioznov   +8 more
doaj   +1 more source

Increasing uptake of influenza vaccine by pregnant women post H1N1 pandemic: a longitudinal study in Melbourne, Australia, 2010 to 2014 [PDF]

, 2015
Background: A Melbourne (Australia) university affiliated, tertiary obstetric hospital provides lay and professional education about influenza vaccine in pregnancy annually each March, early in the local influenza season.
McCarthy, Elizabeth Anne, McDonald, Susan, Pollock, Wendy, Sommerville, Maree, Tapper, Lauren   +4 more
core   +3 more sources

GISAID: Global initiative on sharing all influenza data – from vision to reality

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017
Yuelong Shu1, John McCauley2 1. WHO Collaborating Center for Reference and Research on Influenza, Chinese National Influenza Center, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing ...
Y. Shu, J. McCauley
semanticscholar   +1 more source

Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020

American Journal of Transplantation, 2020
Transplant recipients are among the groups for whom the updated recommendations for 2020–2021 influenza vaccination should generally be considered essential, notably in the face of the COVID-19 pandemic.
S. Olsen, E. Azziz‐Baumgartner, Alicia P. Budd, L. Brammer, S. Sullivan, R. Pineda, C. Cohen, A. Fry   +7 more
semanticscholar   +1 more source

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season

MMWR Recommendations and Reports, 2021
Summary This report updates the 2020–21 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2020;69[No. RR-8]).
L. Grohskopf, E. Alyanak, J. Ferdinands, K. Broder, L. Blanton, H. Talbot, A. Fry   +6 more
semanticscholar   +1 more source

SAFETY AND IMMUNOGENICITY OF COLD-ADAPTED RECOMBINANT INFLUENZA VECTOR EXPRESSING ESAT-6 AND AG85А ANTIGENS OF M. TUBERCULOSIS

Вопросы вирусологии, 2017
Recombinant viral vectors represent one of the most promising platforms for creating a new generation of vaccines against tuberculosis. We constructed a vaccine candidate based on a cold-adapted influenza vector with a truncated NS1 protein containing an
M. V. Sergeeva, A. A. Pulkina, K. A. Vasiliev, E. A. Romanovskaya-Romanko, A. B. Komissarov, O. A. Kuchur, A. Yu. Egorov, L. M. Tsybalova, M. A. Stukova   +8 more
doaj   +1 more source

No temporal association between influenza outbreaks and invasive pneumococcal infections [PDF]

, 2008
Objective: To assess whether the influenza peak in populations precedes the annual peak for invasive pneumococcal infections (IPI) in winter.Design: Ecological study.
Arenz, Stephan, Heininger, Ulrich, Kries, Wolfram and Weigl, Toschke, Andre Michael   +3 more
core   +1 more source

Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.

JAMA Neurology, 2020
Importance It is uncertain whether coronavirus disease 2019 (COVID-19) is associated with a higher risk of ischemic stroke than would be expected from a viral respiratory infection. Objective To compare the rate of ischemic stroke between patients with
A. Merkler, Neal S. Parikh, Saad Mir, Ajay Gupta, H. Kamel, E. Lin, J. Lantos, E. Schenck, P. Goyal, Samuel S. Bruce, J. Kahan, Kelsey N. Lansdale, Natalie M LeMoss, S. Murthy, P. Stieg, M. Fink, C. Iadecola, A. Segal, Marika M. Cusick, T. Campion, Iván Díaz, Cenai Zhang, B. Navi   +22 more
semanticscholar   +1 more source

CROSS-PROTECTIVE PROPERTIES OF AN INFLUENZA VACCINE BASED ON HBC4M2E RECOMBINANT PROTEIN

Вопросы вирусологии, 2018
One of the main problems in the area of influenza prophylaxis and pandemic prevention is the development of cross-reactive vaccines, i.e. vaccines directed against all subtypes of human influenza viruses.
L. M. Tsybalova, L. A. Stepanova, M. A. Shuklina, S. V. Petrov, A. A. Kovaleva, M. V. Potapchuk, A. A. Shaldzhan, Y. A. Zabrodskaya, V. V. Egorov   +8 more
doaj   +1 more source